Perjeta Purple Book BLA 125409
- BLA number
- 125409
- Proprietary names
- Perjeta
- Proper names
- pertuzumab
- Applicant
- Genentech, Inc.
- Center
- CDER
- First observed release
- 2020-05-01
- Latest observed release
- 2026-06-01
- Newest archive release
- 2026-06-01
- FDA patent list
- 47 patents listed; source updated 2025-06-11
- Coverage
- Present in newest release
Latest Known Product Presentations#
Product, Proprietary name, Proper name table| Product | Proprietary name | Proper name | License type | Strength | Dosage form | Route | Presentation | Marketing | Licensure | Approval | Patent list provided |
|---|
| 001 | Perjeta | pertuzumab | 351(a) | 420MG/14ML | Injection | Intravenous | Single-Dose Vial | Rx | Licensed | 2012-06-08 | YES |
Biosimilar And Interchangeable Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 761450 | Poherdy | pertuzumab-dpzb | 351(k) Interchangeable | Rx | 2026-06-01 |
Published Patent List#
Patent, Expiration, Source updated table| Patent | Expiration | Source updated |
|---|
| 11,077,189 | 2039-03-14 | 2025-06-11 |
| 11,992,529 | 2039-03-14 | 2025-06-11 |
| 11,638,756 | 2038-02-28 | 2025-06-11 |
| 12,128,103 | 2038-02-28 | 2025-06-11 |
| 12,145,998 | 2034-09-07 | 2025-06-11 |
| 9,815,904 | 2034-04-15 | 2025-06-11 |
| 9,969,811 | 2034-04-15 | 2025-06-11 |
| 10,017,732 | 2034-03-14 | 2025-06-11 |
| 10,131,873 | 2034-03-14 | 2025-06-11 |
| 10,676,710 | 2034-03-14 | 2025-06-11 |
| 10,829,732 | 2034-03-14 | 2025-06-11 |
| 9,493,744 | 2034-02-24 | 2025-06-11 |
| 10,184,106 | 2033-03-15 | 2025-06-11 |
| 10,087,237 | 2032-01-21 | 2025-06-11 |
| 8,652,474 | 2031-09-28 | 2025-06-11 |
| 10,662,237 | 2031-08-07 | 2025-06-11 |
| 8,512,983 | 2031-01-04 | 2025-06-11 |
| 11,414,498 | 2030-12-23 | 2025-06-11 |
| 10,982,003 | 2030-08-06 | 2025-06-11 |
| 11,225,513 | 2030-08-06 | 2025-06-11 |
| 12,103,975 | 2030-08-06 | 2025-06-11 |
| 9,714,293 | 2030-08-06 | 2025-06-11 |
| 11,639,395 | 2029-07-30 | 2025-06-11 |
| 9,181,346 | 2029-07-18 | 2025-06-11 |
| 9,493,548 | 2029-06-22 | 2025-06-11 |
| 10,689,457 | 2029-06-15 | 2025-06-11 |
| 11,655,305 | 2029-06-15 | 2025-06-11 |
| 11,597,776 | 2029-01-28 | 2025-06-11 |
| 12,110,341 | 2029-01-28 | 2025-06-11 |
| 10,808,037 | 2028-07-08 | 2025-06-11 |
| 11,078,294 | 2028-07-08 | 2025-06-11 |
| 11,976,127 | 2028-07-08 | 2025-06-11 |
| 11,987,637 | 2028-07-08 | 2025-06-11 |
| 11,987,638 | 2028-07-08 | 2025-06-11 |
| 11,999,791 | 2028-07-08 | 2025-06-11 |
| 12,098,211 | 2028-07-08 | 2025-06-11 |
| 12,145,997 | 2028-07-08 | 2025-06-11 |
| 12,173,080 | 2028-07-08 | 2025-06-11 |
| 8,574,869 | 2028-07-08 | 2025-06-11 |
| 11,261,238 | 2028-05-28 | 2025-06-11 |
| 8,372,396 | 2026-07-19 | 2025-06-11 |
| 8,404,234 | 2026-07-03 | 2025-06-11 |
| 11,034,754 | 2026-05-23 | 2025-06-11 |
| 9,631,007 | 2026-05-23 | 2025-06-11 |
| 7,449,184 | 2026-03-12 | 2025-06-11 |
| 9,017,671 | 2025-10-19 | 2025-06-11 |
| 7,862,817 | 2025-06-01 | 2025-06-11 |
Official Monthly Change Events#
Release, Event, Product table| Release | Event | Product | Name | License type | Status | Applicant |
|---|
| 2025-06-01 | U | 001 | Perjeta | 351(a) | Rx | Genentech, Inc. |
| 2020-08-01 | U | 001 | Perjeta | 351(a) | Rx | Genentech, Inc. |
| 2020-05-01 | R | 001 | Perjeta | 351(a) | Rx | Genentech, Inc. |
Observed Product State History#
Release, Product, Name table| Release | Product | Name | License type | Marketing | Licensure | Approval |
|---|
| 2020-05-01 | 001 | Perjeta | 351(a) | Rx | Licensed | 2012-06-08 |